Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes
- PMID: 17950557
- DOI: 10.1016/j.diagmicrobio.2007.09.007
Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes
Abstract
A retrospective study was performed in a university-affiliated referral center from year 1999 to year 2004 to understand the trend of resistance in Stenotrophomonas maltophilia isolates associated with nosocomial infections and describe the emergence of an extensively drug-resistant S. maltophilia (XDRSM). A 49% increase in all types of nosocomial infections and an 85% increase in nosocomial bloodstream infections caused by S. maltophilia were noted over the 5-year period. Trends of resistance to 7 antimicrobial agents against S. maltophilia remained stable. Seventeen patients had positive cultures of XDRSM in the year 2004, including 6 with pneumonia and 1 with biliary tract infection, and the other 10 patients had XDRSM colonization. Twelve patients (70.6%) had positive cultures of non-XDRSM prior to the acquisition of XDRSM. The mortality rate of patients with XDRSM infection was higher than those with colonization (85.7% versus 10%, P = 0.004). XDRSM infection, presence of shock, and the number of dysfunctional organ systems at the time of XDRSM isolation were significantly associated with in-hospital mortality (P < 0.05). Genotyping of the 17 XDRSM isolates revealed 16 different clones. All the isolates tested possessed class 1 integron and formed biofilms and melanin. The high genotypic heterogeneity among XDRSM isolates was indicative of the polyclonal nature of emergence of these resistant bacteria. Majority of patients had positive cultures of non-XDRSM prior to the acquisition of XDRSM, indicating that the use of antibiotics might have resulted in selection of XDRSM.
Similar articles
-
[Nosocomial Stenotrophomonas maltophilia infections in a university hospital].Mikrobiyol Bul. 2005 Jan;39(1):25-33. Mikrobiyol Bul. 2005. PMID: 15900834 Turkish.
-
Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.Ther Apher Dial. 2009 Jun;13(3):193-8. doi: 10.1111/j.1744-9987.2009.00693.x. Ther Apher Dial. 2009. PMID: 19527465
-
Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.J Microbiol Immunol Infect. 2006 Apr;39(2):144-9. J Microbiol Immunol Infect. 2006. PMID: 16604247
-
Optimizing therapy for Stenotrophomonas maltophilia.Semin Respir Crit Care Med. 2007 Dec;28(6):672-7. doi: 10.1055/s-2007-996414. Semin Respir Crit Care Med. 2007. PMID: 18095231 Review.
-
Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.Clin Infect Dis. 2007 Dec 15;45(12):1602-9. doi: 10.1086/522998. Clin Infect Dis. 2007. PMID: 18190323 Review.
Cited by
-
A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada.Can J Infect Dis Med Microbiol. 2012 Winter;23(4):165-9. doi: 10.1155/2012/762571. Can J Infect Dis Med Microbiol. 2012. PMID: 24294268 Free PMC article.
-
Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia.Jundishapur J Microbiol. 2015 Aug 22;8(8):e23569. doi: 10.5812/jjm.23569. eCollection 2015 Aug. Jundishapur J Microbiol. 2015. PMID: 26468367 Free PMC article.
-
The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim/sulfamethoxazole.Ann Lab Med. 2015 Mar;35(2):246-9. doi: 10.3343/alm.2015.35.2.246. Epub 2015 Feb 12. Ann Lab Med. 2015. PMID: 25729729 Free PMC article.
-
Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa.Jundishapur J Microbiol. 2014 Dec 10;8(1):e13975. doi: 10.5812/jjm.13975. eCollection 2015 Jan. Jundishapur J Microbiol. 2014. PMID: 25789125 Free PMC article.
-
Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.Support Care Cancer. 2018 Jun;26(6):1953-1960. doi: 10.1007/s00520-017-4032-x. Epub 2018 Jan 7. Support Care Cancer. 2018. PMID: 29307014
MeSH terms
LinkOut - more resources
Full Text Sources